Background: Like all medical innovations, telestroke must demonstrate successful outcomes to achieve sustained growth and acceptance. Asserting that telemedicine is faster, employs the latest technology, or promotes a better use of limited resources is laudable but insufficient. An analysis of stroke treatment within a telemedicine network in 2013 showed that tissue-type plasminogen activator (tPA) could be safely and reliably administered within a practice-based model of telestroke care. Since then, hospital volume and tPA administration within this network have tripled. We hypothesize that a practice-based model of telestroke can maintain positive outcomes in the face of rapid growth. Methods: Data on tPA treatment times and 
Introduction
Early intravenous tissue-type plasminogen activator (tPA) administration for acute ischemic stroke improves patient outcomes in a highly time-dependent manner. [1] [2] [3] Telestroke, the application of telemedicine for rapid stroke diagnosis and treatment, facilitates tPA use by allowing a neurologist to remotely evaluate a patient. The need for high-quality telestroke care remains high and will rise with recent demonstrations of the benefit of thrombectomy in select stroke patients. 4 While long a bastion of academic centers, an analysis of telestroke in 2013 showed that tPA could be safely and reliably administered within a practice-based model of telestroke care. 5 Since then, hospital volume and tPA administration within this network have tripled. We hypothesize that a practice-based model of telemedicine can maintain positive outcomes in the face of rapid growth and, in so doing, serve as a model for continued improvement in stroke care.
Methods
AcuteCare Telemedicine's (ACT) 4 practice-based neurologists evaluated patients with neurological emergencies using 2 commercially available telemedicine systems. 6, 7 Between November 1, 2012, and November 30, 2014, ACT's network grew from 7 to 20 hospitals, ranging from 35 to 420 beds. In these Georgia, Alabama, South Carolina, and Tennessee hospitals, emergency room physicians initiated telemedicine consultations by phone to obtain a telestroke consultation. Patients believed to exhibit signs of acute stroke had telestroke video evaluations. Data were extracted for all stroke patients treated with tPA over the course of the study period.
We collected demographic information and phone response time (time from ACT notification to emergency room callback) from our database. We analyzed outcomes of tPAtreated patients by reviewing discharge summaries and associated hospital notes. Primary outcome measures were the median door-to-needle (DTN) time for tPA administration, the median call-to-needle (CTN) time, and final diagnosis. DTN was calculated as the difference between patient arrival time and tPA bolus time, whereas CTN was defined as the span between the requesting physicians' call to ACT and the tPA bolus time. Secondary outcome measures included the door-to-call (DTC) time, onset-toneedle (OTN) time, and call-to-response (CTR) time. DTC was calculated as the window between patient arrival time and the initial call to ACT. CTR, the portion of the DTN window directly attributable to the telestroke service provider, is the span between the requesting physicians' call and ACT's callback. OTN is the time window between the documented stroke symptom onset and tPA bolus. The investigation was a retrospective analysis and patients' information was anonymized and an institutional review board exemption was obtained.
Comparisons between the 2 studies were evaluated using the Wilcoxon rank sum test for continuous variables and Fisher's exact test for categorical variables. All P values were 2-sided and P values less than .05 were considered significant. Statistical analysis was performed using the software SAS (version 9.3; the SAS Institute, Cary, NC).
Results
In the study period, ACT conducted 1653 phone consultations leading to 706 video evaluations and 165 tPA treatments. The demographic characteristics of the patients treated with intravenous tPA are outlined in Table 1 along with data from our first study. There was no significant difference in patient demographics in this study versus ACT's first study: age, gender, National Institutes of Health Stroke Scale (NIHSS) score, or any of the outcome measures (hemorrhage, mortality, and length of stay). CTR time did not change. Analysis of large versus small hospitals and weekend versus weekday presentation revealed no significant difference in treatment times or outcomes. We saw a trend toward improved treatment time in all individual hospitals. The average NIHSS score of tPA patients was 9.8. The symptomatic hemorrhage rate was 5% and 57% of patients were discharged home. Table 2 shows primary and secondary outcome measures. DTN was excluded in 23 patients (13.9%) with invalid or missing arrival or treatment times. DTC was excluded in 20 patients (12.1%) and CTN was excluded in 4 patients (2.4%). ACT's CTR was available for all 165 tPA patients. 
Discussion
This study demonstrates meaningful improvement in markers of telestroke efficiency in the face of rapid growth of a telestroke network. Comparing our earlier data to this new data set, we saw a statistically significant improvement in 3 time intervals leading to a total reduction Despite the growth of the telestroke network, CTR did not decline. Furthermore, these data suggest that participation in a telestroke network for stroke care can help hospitals improve their processes and ultimately their stroke outcomes. Examination of telestroke outcomes provides clear evidence of its value and shows that telestroke is an important component of health-care systems' efforts to reduce DTN. 4 Identifying the factors leading to improvement promotes best telestroke practices. 8 All of our hospitals showed positive trends that support the power of cumulative experience and possibly an effect of their processes being under close observation (i.e., the Hawthorne effect). One might argue that as the telestroke system grew, it attracted larger, better organized hospitals. Yet we did not see a correlation between primary end points and hospital size. Still, many of our hospitals are primary stroke centers with active coordinators whose continuous work undoubtedly improved stroke treatment processes and outcomes. However, it is equally clear that several factors are attributable directly to the telestroke providers, and these factors are summarized in Table 3 .
Some of our hospitals are in their sixth year of telestroke and others have just started. A learning curve would therefore apply to both the hospitals and telestroke providers; faster tPA treatment times result from more experience. This was reported in a large recent European study, but unlike the current study, they found that smaller hospitals did not improve their treatment times. 2 Further analysis of process and outcomes will include a deeper look at the subintervals in the DTN: call-todecision, video-to-decision, and decision-to-treatment times.
To our knowledge, this is the first consistently reported series of practice-based telestroke outcomes. Asserting that telemedicine is faster, employs the latest technology, or promotes a better use of limited resources is laudable but insufficient. Like all medical innovations, telestroke must demonstrate successful outcomes and improved care to achieve sustained growth and acceptance. This study demonstrates that and serves as support for increased utilization of telestroke and perhaps telemedicine in general. Poor response times and physician burnout adversely affect care. A desultory rollout of telestroke, without attention to those factors listed in Table 3 , will lead to hospital, physician, and patient dissatisfaction. 
